The study drug is a potential new treatment for atherosclerosis, which is the build-up of plaque (fats, cholesterol, and other substances) in and on the walls of the arteries. Plaque can cause arteries to narrow, which blocks the blood flow in the vessels.
Atherosclerosis is a common cause of heart attack, stroke, and cardiovascular diseases. Currently there are various treatments available, but they have significant side effects or are not very effective. That is why there is a need to develop new treatments for atherosclerosis.
Study Schedule: 1x 9 night inpatient stay & 1x 6 night inpatient stay, 3 follow-up visits.
This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.
Call us on 1800 243 733 to discuss your eligibility today!